MedTrace Logo

Clinical Validation of PROPECG-TMT

NCT06624852 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2024-10-03

No results posted yet for this study

Summary

This clinical validation evaluates the performances of physicians with and without learning with PROPECG-TMT assistance for screening coronary artery revascularization on TMT-ECG.

There are two endpoints used to evaluate performances: Accuracy (primary endpoints with pair specificity/sensitivity, and PPV/NPV), and time needed for screening (secondary endpoints with time measurements in all cases).

Conditions

Interventions

OTHER

Screening for coronary artery revascularization based on TMT-ECG

Screening for coronary artery revascularization based on TMT-ECG with and without the assistance of PROPECG-TMT

Sponsors & Collaborators

  • Yonsei University

    lead OTHER

Eligibility

Min Age
21 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-02-13
Primary Completion
2024-02-13
Completion
2024-02-13

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06624852 on ClinicalTrials.gov